Risks of Suicide and Poisoning Among Elderly Patients Prescribed Selective Serotonin Reuptake Inhibitors: A Retrospective Cohort Study
J Clin Psychiatry 2008;69(3):349-357
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: Treatment with selective serotonin reuptake
inhibitors (SSRIs) has been associated with increased suicide risk. Risks of
suicide death and of poisoning were compared during periods of SSRI treatment
versus periods without any antidepressant treatment among elderly patients.
Method: In this retrospective cohort study, records from the
Quebec Health Care Fund and Vital Statistics databases were obtained for
patients 65 years and older who had filled a prescription for an SSRI between
January 1998 and December 2004. Patients were followed from the filling date of
the first SSRI prescription during the study period until death, the end of the
first period extending for at least 365 days with no antidepressant supply, or
December 31, 2004, whichever occurred first.
Results: The cohort included 128,229 patients (mean age = 75.4
years), 70% of whom were women. Numbers of suicide deaths (crude rate/100,000
patient-years) were 37 (23) during SSRI use, 16 (51) during other
antidepressant use, 5 (54) during use of both an SSRI and another
antidepressant, and 29 (29) during no antidepressant use. The adjusted risk of
suicide death (Cox regression model with time-dependent exposure) was not
higher during SSRI use versus nonuse (hazard ratio [95% CI]): any SSRI = 0.64
(0.38 to 1.07), paroxetine = 0.71 (0.37 to 1.35), citalopram = 1.16 (0.59 to
2.25), and sertraline = 0.38 (0.16 to 0.93). The adjusted hazard ratio (95% CI)
of poisoning was higher during SSRI use versus nonuse (1.16 [1.07 to 1.25]) and
varied between SSRI agents from 0.93 (0.74 to 1.16) for fluoxetine to 1.45
(1.23 to 1.71) for fluvoxamine.
Conclusion: Among elderly patients dispensed SSRIs, the risk
of suicide death was not higher during periods of SSRI use compared to when
antidepressants were not being used.